Atai Life Sciences N.V. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 26.71 million compared to USD 33.14 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.21 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.405 USD | -5.07% | -10.83% | -0.71% |
05-23 | Atai Life Sciences N.V. Announces Board and Supervisory Board Changes | CI |
05-22 | Clarify Pharma confirms name change to File Forge | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.71% | 248M | |
+53.62% | 59.28B | |
+41.42% | 40.94B | |
-5.51% | 40.17B | |
-5.16% | 28.69B | |
+12.41% | 26.63B | |
-20.79% | 18.89B | |
+30.84% | 12.46B | |
+0.03% | 12.42B | |
+26.45% | 12.26B |
- Stock Market
- Equities
- ATAI Stock
- News Atai Life Sciences N.V.
- Atai Life Sciences N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024